Chemical inhibitors of 1700003F12Rik can impede the protein's function through interference with various signaling pathways that are essential for its activity. The compound SB203580 is known for its inhibitory effect on p38 MAP kinase, a pivotal enzyme in cell stress response signaling, which 1700003F12Rik may utilize for its function. Similarly, PD98059 targets MEK, an upstream component of the MAPK/ERK pathway, which could disrupt the signaling relay that 1700003F12Rik engages in. LY294002 and Wortmannin both act on PI3K, a key modulator of intracellular signaling, and their inhibition can impair the PI3K/AKT pathway, a possible conduit for 1700003F12Rik's signal transduction processes. SP600125 targets the JNK pathway, which may impair any JNK-dependent signaling involving 1700003F12Rik, while U0126, another MEK1/2 inhibitor, could further reduce the ERK pathway signaling that might be crucial for 1700003F12Rik's function.
Further down the cascade, Y-27632 inhibits ROCK, a kinase involved in the Rho/ROCK signaling pathway, which could disrupt 1700003F12Rik's role in cellular processes regulated by this pathway. Rapamycin, on the other hand, acts on mTOR, a central regulator of cell growth and proliferation, inhibition of which could impinge on signaling pathways that 1700003F12Rik is part of. PP2 and Dasatinib are both inhibitors of Src family tyrosine kinases, with Dasatinib also inhibiting BCR-ABL, and their action could dampen the activity of pathways that involve 1700003F12Rik. Bisindolylmaleimide I targets PKC, which is implicated in a multitude of signaling pathways, and inhibition here could reduce 1700003F12Rik signaling. Lastly, Staurosporine broadly targets protein kinases, which may include those that interact with or regulate 1700003F12Rik, thereby leading to functional inhibition of the protein through a wide-reaching impact on cellular kinase activity. Each chemical, through its specific target, can culminate in the inhibition of 1700003F12Rik by dismantling the necessary signaling infrastructure it requires to function effectively within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAP kinase, which 1700003F12Rik may utilize in cell stress response signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which is upstream in the MAPK/ERK pathway, affecting 1700003F12Rik signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, possibly disrupting pathways that 1700003F12Rik relies on for signal transduction. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, potentially impairing JNK-dependent signaling involving 1700003F12Rik. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK1/2, thereby potentially inhibiting ERK pathway signaling involving 1700003F12Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, which could lead to functional inhibition of 1700003F12Rik in PI3K/AKT pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Inhibits ROCK, which may disrupt Rho/ROCK signaling pathways that include 1700003F12Rik. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, which could inhibit signaling pathways critical to 1700003F12Rik's function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
Inhibits Src family tyrosine kinases, potentially disrupting pathways involving 1700003F12Rik. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Inhibits BCR-ABL and Src family kinases, possibly inhibiting pathways with 1700003F12Rik. | ||||||